Filing Details

Accession Number:
0000899243-21-044154
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-10 19:34:28
Reporting Period:
2021-11-10
Accepted Time:
2021-11-10 19:34:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1496671 Calithera Biosciences Inc. CALA Pharmaceutical Preparations (2834) 272366329
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1553389 Susan Molineaux C/O Calithera Biosciences, Inc.
343 Oyster Point Blvd. #200
South San Francisco CA 94080
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-10 100,000 $0.85 557,188 No 4 P Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 102,500 Indirect By Spouse
Common Stock 97,500 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8152 to $0.8791, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
  2. Shares are held by the Molineaux Family Trust of which the Reporting Person is a Trustee.
  3. Includes 2,500 shares acquired on June 10, 2021, under the Company's 2014 Employee Stock Purchase Plan.